Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ATOS

ATOSSA THERAPEUTICS, INC.

CIK 0001488039 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$2.54
↓ 0.05 (-1.93%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$25.35M
P/E Ratio
-0.67
EPS
-4.04
Dividend Yield
Not covered
52W Position
29%
Beta
1.03

Valuation multiples

Fwd P/E
7.04
PEG
0.00
P/B
0.94
P/S
Not covered
EV/Revenue
Not covered
ROE
-140.5%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 29%
$0.53$7.56

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$34.77M
Total Assets
$47.61M
Free Cash Flow
-$29.79M

Recent news